ABU DHABI / WAM H.H. Sheikh Abdullah bin Zayed Al Nahyan, Deputy Prime Minister and ...
Read More »Mubadala’s ‘KELIX bio’ acquires Julphar’s ‘DiabTec’
ABU DHABI/WAM KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens Mubadala’s portfolio of biologicals, establishes its role in biomanufacturing across the MENA region, and supports its efforts to advance the UAE’s life sciences sector through local manufacturing. DiabTec’s facility includes 20,000-liter ...
Read More »